Lorazepam
Lorazepam Injection, USP
Approved
Approval ID
a3e2fbad-d850-4bac-9a45-dc1e75e37cab
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 15, 2011
Manufacturers
FDA
TYA Pharmaceuticals
DUNS: 938389038
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lorazepam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code64725-6044
Application NumberNDA018140
Product Classification
M
Marketing Category
C73594
G
Generic Name
Lorazepam
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 1, 2012
FDA Product Classification
INGREDIENTS (4)
LORAZEPAMActive
Quantity: 2.0 mg in 1 mL
Code: O26FZP769L
Classification: ACTIB
POLYETHYLENE GLYCOL 400Inactive
Quantity: 0.18 mL in 1 mL
Code: B697894SGQ
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT